Insight

Photo from The Institute of Cancer Research/LinkedIn

Sep 7, 2024, 15:31

Potential drug to target a rare childhood brain tumour – ICR

The Institute of Cancer Research (ICR) shared a post on LinkedIn:

“News: Research reveals a potential drug to target a rare childhood brain tumour.

ICR scientists and Dana-Farber Cancer Institute found a key weakness in the tumour cells which could be targeted by ribociclib, a drug already used to treat breast cancer.

Read more about the research, funded by The Brain Tumour Charity.”

Potential drug to target a rare childhood brain tumour - ICR

Source: The Institute of Cancer Research/LinkedIn

More posts featuring The Institute of Cancer Research on oncodaily.com

cancer childhood brain tumour Dana-Farber Cancer Institute ICR OncoDaily Oncology Ribociclib The Brain Tumour Charity The Institute of Cancer Research

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage